Treosulfan with fludarabine recommended for malignant disease before allogeneic stem cell transplant

NICE Technology appraisal guidance [TA640] shows some groups are less likely to die from the transplant or associated complications if they have treosulfan and fludarabine instead of busulfan and fludarabine.

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date

Existing members Sign in